Mallinckrodt was the third opioid maker to seek Chapter 11 bankruptcy protection.

Shareholders in Mallinckrodt, the Dublin-based but US-run drugmaker in the middle of a bankruptcy reorganisation, are being urged by a leading corpor(...)